Nektar Therapeutics (NKTR)
0.7383
-0.02
(-2.57%)
USD |
NASDAQ |
Mar 28, 16:00
0.71
-0.03
(-3.83%)
After-Hours: 20:00
Nektar Therapeutics Max Drawdown (5Y): 99.39% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Corcept Therapeutics Inc | 60.35% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.60% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.72% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -59.20 |
| Beta (5Y) | 0.6486 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 76.37% |
| Historical Sharpe Ratio (5Y) | -0.6537 |
| Historical Sortino (5Y) | -1.053 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.90% |